However, data associating hyperprolactinemia with other comorbidities such as obesity, metabolic syndrome, diabetes, and cardiovascular risk raise the question if serum PRL levels should be always normalized (9). This evidence concerns the gene PRL and obesity due to melanocortin 4 receptor deficiency.